Found: 1
Select item for more details and to access through your institution.
Durable remission for four pediatric patients with high‐risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 6, p. 1, doi. 10.1002/pbc.29649
- By:
- Publication type:
- Article